Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-24-000166
Filing Date
2024-08-05
Accepted
2024-08-05 15:54:43
Documents
102
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20240630.htm   iXBRL 10-Q 3009757
2 EX-31.1 pfe-exh311x6302024x10q.htm EX-31.1 9076
3 EX-31.2 pfe-exh312x6302024x10q.htm EX-31.2 9068
4 EX-32.1 pfe-exh321x6302024x10q.htm EX-32.1 4511
5 EX-32.2 pfe-exh322x6302024x10q.htm EX-32.2 4492
  Complete submission text file 0000078003-24-000166.txt   15548658

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240630.xsd EX-101.SCH 93906
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20240630_cal.xml EX-101.CAL 173914
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240630_def.xml EX-101.DEF 482874
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240630_lab.xml EX-101.LAB 1004799
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240630_pre.xml EX-101.PRE 731770
104 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240630_htm.xml XML 3248324
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 241174580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)